[HTML][HTML] New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults
Within 6 months of the coronavirus pandemic, a new disease entity associated with a
multisystem hyperinflammation syndrome as a result of a previous infection with the SARS …
multisystem hyperinflammation syndrome as a result of a previous infection with the SARS …
[HTML][HTML] Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019
JH Kwak, SY Lee, JW Choi - Clinical and experimental pediatrics, 2021 - ncbi.nlm.nih.gov
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading worldwide since …
syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading worldwide since …
Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in …
N Ouldali, J Toubiana, D Antona, E Javouhey, F Madhi… - Jama, 2021 - jamanetwork.com
Importance Multisystem inflammatory syndrome in children (MIS-C) is the most severe
pediatric disease associated with severe acute respiratory syndrome coronavirus 2 infection …
pediatric disease associated with severe acute respiratory syndrome coronavirus 2 infection …
COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves
TR Hennon, OA Karl, MD Penque, R Abdul-Aziz… - Progress in Pediatric …, 2021 - Elsevier
Multisystem inflammatory syndrome of children (MIS-C) continues to be a highly concerning
diagnosis in those recently infected with SARS-CoV-2. The diagnosis of MIS-C cases will …
diagnosis in those recently infected with SARS-CoV-2. The diagnosis of MIS-C cases will …
[HTML][HTML] Current insights into the pathophysiology of multisystem inflammatory syndrome in children
LA Vella, AH Rowley - Current pediatrics reports, 2021 - Springer
Abstract Purpose of Review We highlight the new clinical entity multisystem inflammatory
syndrome in children (MIS-C), the progress in understanding its immunopathogenesis, and …
syndrome in children (MIS-C), the progress in understanding its immunopathogenesis, and …
Multisystem inflammatory syndrome in children (MIS‐C) associated with 2019 novel coronavirus (SARS‐CoV‐2) infection
We report three critically ill pediatric patients (aged 6–10 years), presenting with features of
multisystem inflammatory syndrome in children (MIS‐C) from April 4 to May 10, 2020, to a …
multisystem inflammatory syndrome in children (MIS‐C) from April 4 to May 10, 2020, to a …
Short-term outcomes of corticosteroid monotherapy in multisystem inflammatory syndrome in children
DS Villacis-Nunez, K Jones, A Jabbar, L Fan… - JAMA …, 2022 - jamanetwork.com
Importance Optimal agents and duration of primary treatment for multisystem inflammatory
syndrome in children (MIS-C) remain unclear. Objective To compare short-term patient …
syndrome in children (MIS-C) remain unclear. Objective To compare short-term patient …
IVIG compared with IVIG plus infliximab in multisystem inflammatory syndrome in children
LD Cole, CM Osborne, LJ Silveira, S Rao… - …, 2021 - publications.aap.org
OBJECTIVES To compare initial treatment with intravenous immunoglobulin (IVIG) versus
IVIG plus infliximab in multisystem inflammatory syndrome in children (MIS-C). METHODS …
IVIG plus infliximab in multisystem inflammatory syndrome in children (MIS-C). METHODS …
[PDF][PDF] Clinical characteristics and outcomes of multisystem inflammatory syndrome in children (MIS-C): a national multicenter cohort in Saudi Arabia
Abstract Background: In children, Coronavirus Disease 2019 (COVID-19) is usually mild.
However, children can be seriously impacted in rare situations, and clinical manifestations …
However, children can be seriously impacted in rare situations, and clinical manifestations …